The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class…
Read More »donanemab
:max_bytes(150000):strip_icc()/LLYChart-dc2ea21210634f1fa9bc9dbf14ffe9b9.GIF?w=780&resize=780,470&ssl=1 "Eli Lilly Stock Gains After FDA Advisors Recommend Alzheimer’s Drug Donanemab")
Key Takeaways Eli Lilly shares rose in extended-hours trading on Monday after a panel of independent advisors unanimously recommended the…
Read More »
An advisory committee to the Food and Drug Administration has recommended that the federal agency approve Alzheimer’s drug donanemab. Andrew…
Read More »